Sickle cell has been overlooked for far too long. Fortunately, there are new breakthroughs in sickle cell treatment that you ...

Prime Medicine’s modular editing tech may lower off-target risk, but key data and funding milestones remain ahead. Find out ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Strategic pipeline prioritization with workforce and cost reductions expected to extend the company's cash runway by one year into H2 2027 -- -- Two robust clinical datasets from CB-010 and CB-011 ...

We expect investors to focus on the sales numbers of CRISPR Therapeutics’ CRSP sole-marketed product, Casgevy, and other ...

Repare Therapeutics Inc. ("Repare" or the "Company") , a leading clinical-stage precision oncology company, today announced the acceptance of two abstracts for mini-oral presentation and the ...

Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...

Caribou is scaling back its operations, halting multiple programmes, and cutting staff to focus on two cancer programmes.

The CRISPR company is laying off about a third of its employees and stopping work on an experimental lupus treatment in a bid ...

We also talk about today’s DNA-related advances that use machine learning to design tailored Cas9 proteins, and multiple sequencing technologies to study mutation rates in four generations of the same ...

A team at UC San Francisco and Gladstone Institutes has developed new drug candidates that show great promise against the ...

Slavé Petrovski, vice president of AstraZeneca’s Centre for Genomics Research, celebrates DNA Day by delving into the world ...